Kristin M. Dittmar

Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy

M. Wing, Lianbo Yu, Russell Bonneville, 2019, Cold Spring Harbor molecular case studies.

Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing

C. Hofmeister, M. Phelps, C. Coss, 2021, European Journal of Drug Metabolism and Pharmacokinetics.

Imprint cytopathology of core needle biopsies: a "first responder" role for cytotechnologists.

A. Laganà, P. Wakely, Kristin M. Dittmar, 2013, Journal of the American Society of Cytopathology.

Interval Magnetic Resonance Imaging: an Alternative to Guidelines for Indeterminate Nodules Discovered in the Cirrhotic Liver

T. Pawlik, S. Black, C. Schmidt, 2017, Journal of Gastrointestinal Surgery.

Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival

M. Dillhoff, P. Bloomston, S. Black, 2016, Front. Oncol..

Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer

Wei Chen, J. Datta, R. Goldberg, 2017, Oncotarget.